Biotech Intraday

Technology Train Wreck Continues

This column is my opinion and expresses my views. Those views can change at a moments notice when the market changes. I am not right all the time and I do not expect to be. I disclose all my positions clearly listed on the page, and I do not trade my account on the stocks spoken of in this column unless fully disclosed. If that does not work for you stop reading and close the page. Do not bother me or harass me.

Otherwise, enjoy the column!

Subscribe to The Market Chronicle to get the Daily Monster Market Commentary and join the 2,892 subscribers getting it for FREE!

Technology shares continue to get wrecked, with the NASDAQ Composite trading down over 2 percent at one point on the day, although as of 3:30 pm has rallied back to down 1.3 percent.

NASDAQ Comp 5 minute chart Technolgy

(Interactive Brokers) 

Technology Program

Unlike past selling days, today does not seem to be program driven. With the patterns not as tightly correlated.

Amazon, Tesla, Facebook, Google, Netflix technology stocks

(Interactive Brokers) 


It appears for now that the Nasdaq has begun to turn and is now trending higher on the one-minute charts.

NASDAQ One minute chart

(Interactive Brokers) 


Subscribe to the The Market Chronicle to get it Daily and join the 2,892 subscribers getting it for FREE!

Even our litmus test stock Tesla has appeared to have formed a double bottom around the $354 level and has moved higher.

Tesla intraday chart

(Interactive Brokers) 


Biotech has moved higher as indicated by the IBB and appears to have bottomed

Biotech Intraday

(Interactive Brokers) 

The sell-off in the Nasdaq and Tech mid-day was steep but for the most part the market has been able to battle back. It is worth noting we have given back all of the gains from yesterday and are now lower than levels seen on June 27.

Want to see our latest Reading the Market Premium Video For Free?

Rotation Out Of Tech Into Biotech

[wysija_form id=”10″]

Of course, you can sign-up and get a free two-week trial as well.

Let Us Write Research For You!

Email Us To Find Out More

Free Articles By Mike

Alibaba Shares Could Be Worth $210


Michael Kramer and the clients of Mott Capital Management, LLC own shares of TSLA.

Michael Kramer is the Founder and Portfolio Manager of Mott Capital Management LLC, a registered investment adviser. Information presented is for educational purposes only and does not intend to make an offer or solicitation for the sale or purchase of any specific securities, investments, or investment strategies. Investments involve risk and unless otherwise stated, are not guaranteed. Be sure to first consult with a qualified financial adviser and/or tax professional before implementing any strategy discussed herein. Upon request, the advisor will provide a list of all recommendation made during the past twelve months. Past performance is not indicative of future performance.

Thanks For Visiting The Market Chronicle!

Sign up to receive more great market content like what you just read sent to your inbox daily!

We don’t spam! Read our privacy policy for more info.